IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q4 2024 Holdings

Filed 2025-01-21 | 6 holdings | $146.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$65.9M3,931,81845.0%
Tectonic Therapeutics, Inc.(TECX)Common Stock878972108$47.5M1,028,67432.5%
Kyverna Therapeutics, Inc.(KYTX)Common Stock501976104$16.9M4,523,92411.6%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$9.6M407,4996.6%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$3.8M1,798,1632.6%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$2.6M2,765,3141.8%